Home > Press > VeruTEK Technologies Announces $6 Million in Equity Financing
Abstract:
VeruTEK Technologies, Inc. (VTKT.OB), a provider of nanotechnology-based green chemistry solutions that eliminate the toxic and harmful effects of chemicals present in the environment, announced the completion of a private placement of equity for approximately $6 million before fees and expenses. The Company intends to use the net proceeds of this offering to broaden market awareness and drive further adoption of its green chemistry solutions. In addition, the Company will use funding for general corporate purposes, including capital expenditures and working capital.
The $6 million offering was for the sale of approximately 2.8 million units. Each unit was purchased for $2.20 and included two shares of common stock and one warrant. Each warrant allows investors to purchase an additional share of common stock at an exercise price of $1.30 per share and can be exercised for a period of five years.
Needham & Company, LLC acted as sole placement agent in this offering.
The securities described in this announcement have not been registered under the Securities Act of 1933, as amended, or any state securities of "blue sky" laws, and the securities may not be offered or sold absent registration or an applicable exemption from registration requirements. This press release does not and shall not constitute an offer to sell or the solicitation of an offer to buy securities.
####
About VeruTEK Technologies, Inc.
VeruTEK Technologies, Inc. (VTKT.OB) develops, formulates and markets, proprietary patent-pending green chemistry solutions for a number of applications including the remediation of surface and subsurface soil and groundwater contamination. VeruTEK provides clean, green and sustainable solutions for many cases of environmental contamination.
Safe Harbor Statement
Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, the risks associated with the events described in this press release, future development of VeruTEK's products, and other risks identified in VeruTEK's filings with the Securities and Exchange Commission. Further information on risks faced by VeruTEK are detailed under the caption "Risk Factors" in VeruTEK's Annual Report on Form 10-KSB for the year ended December 31, 2007 and our subsequent Quarterly Reports on Form 10-Q. These filings are available on a website maintained by the Securities and Exchange Commission at http://www.sec.gov. The information contained in this press release is accurate as of the date indicated. Actual results, events or performance may differ materially. VeruTEK undertakes no obligation to publicly release the result of any revision to these forward- looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
For more information, please click here
Contacts:
VeruTEK Technologies, Inc.
Jim Carini
312-953-8319
Copyright © Business Wire 2008
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Environment
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
New method in the fight against forever chemicals September 13th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||